The aim of our study was to assay circulating IL-15 and IL-6 levels in patients with newly diagnosed AD, their first-degree relatives, and healthy controls in comparison with the presence of anti-islet antibodies and insulin resistance. This evidence concerns the gene IL15 and Insulin resistance.